StocksFundsScreenerSectorsWatchlists
CLVR

CLVR - Clever Leaves Holdings Inc. Stock Price, Fair Value and News

5.01USD+0.11 (+2.24%)Delayed as of 28 Mar 2024, 02:07 pm ET

Market Summary

CLVR
USD5.01+0.11
Delayedas of 28 Mar 2024, 02:07 pm
2.24%

CLVR Stock Price

View Fullscreen

CLVR RSI Chart

CLVR Valuation

Market Cap

8.6M

Price/Earnings (Trailing)

-0.21

Price/Sales (Trailing)

0.46

EV/EBITDA

-0.04

Price/Free Cashflow

-0.58

CLVR Price/Sales (Trailing)

CLVR Profitability

Operating Margin

27.47%

EBT Margin

-271.35%

Return on Equity

-140.22%

Return on Assets

-110.2%

Free Cashflow Yield

-171.89%

CLVR Fundamentals

CLVR Revenue

Revenue (TTM)

18.6M

Rev. Growth (Yr)

33.24%

Rev. Growth (Qtr)

-23.31%

CLVR Earnings

Earnings (TTM)

-41.6M

Earnings Growth (Yr)

74.52%

Earnings Growth (Qtr)

-42.92%

Breaking Down CLVR Revenue

52 Week Range

5.70
(Low)(High)

Last 7 days

38.1%

Last 30 days

5.5%

Last 90 days

110.1%

Trailing 12 Months

1293.9%

How does CLVR drawdown profile look like?

CLVR Financial Health

Current Ratio

2.62

Debt/Equity

0.2

Debt/Cashflow

-2.57

CLVR Investor Care

Shares Dilution (1Y)

42.92%

Diluted EPS (TTM)

-28.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202316.7M17.6M18.6M0
202216.9M17.4M16.2M17.8M
202126.5M28.2M28.3M15.4M
202012.3M16.9M21.4M25.9M
20190007.8M

Tracking the Latest Insider Buys and Sells of Clever Leaves Holdings Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 08, 2024
hague henry r iii
sold
-562
3.3108
-170
chief financial officer
Feb 27, 2024
hague henry r iii
sold
-1,623
3.95
-411
chief financial officer
Jan 19, 2024
fajardo andres
sold
-4,501
2.884
-1,561
chief executive officer
Jan 19, 2024
wilches julian
sold
-377
2.884
-131
chief regulatory officer
Dec 20, 2023
fajardo andres
sold
-360
2.0367
-177
chief executive officer
Dec 20, 2023
wilches julian
sold
-274
2.0367
-135
chief regulatory officer
Jul 18, 2023
hague henry r iii
sold
-335
0.2152
-1,560
chief financial officer
Jul 18, 2023
wilches julian
sold
-174
0.2152
-813
chief regulatory officer

1–10 of 50

Which funds bought or sold CLVR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 11, 2024
VANGUARD GROUP INC
added
2.85
-19,067
31,700
-%
Feb 14, 2024
AMUNDI
unchanged
-
5,825
29,547
-%
Feb 14, 2024
Royal Bank of Canada
new
-
-
-
-%
Feb 14, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
sold off
-100
-388
-
-%
Feb 14, 2024
TWO SIGMA SECURITIES, LLC
reduced
-24.03
-118
438
-%
Feb 14, 2024
Penserra Capital Management LLC
unchanged
-
-7,000
10,000
-%
Feb 14, 2024
Davidson Kempner Capital Management LP
unchanged
-
-936
3,969
-%
Feb 14, 2024
Walleye Capital LLC
unchanged
-
273
8,062
-%
Feb 14, 2024
Skaana Management L.P.
unchanged
-
174
5,134
-%
Feb 13, 2024
RENAISSANCE TECHNOLOGIES LLC
added
20.54
-26,000
72,000
-%

1–10 of 30

Are Funds Buying or Selling CLVR?

Are funds buying CLVR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CLVR
No. of Funds

Unveiling Clever Leaves Holdings Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jan 23, 2024
farallon capital management llc
0.0%
0
SC 13G/A
May 23, 2023
detwiler kyle
4.9%
2,224,241
SC 13D/A
Apr 03, 2023
schultze special purpose acquisition sponsor, llc
5.0%
2,248,844
SC 13D/A
Feb 09, 2023
farallon capital management llc
6.1%
2,668,551
SC 13G/A
Feb 14, 2022
farallon capital management llc
9.99%
2,719,118
SC 13G/A
Feb 14, 2022
etf managers group, llc
3.54%
949,286
SC 13G/A
Feb 07, 2022
schultze special purpose acquisition sponsor, llc
8.4%
2,248,844
SC 13D/A

Recent SEC filings of Clever Leaves Holdings Inc.

View All Filings
Date Filed Form Type Document
Mar 27, 2024
8-K
Current Report
Mar 27, 2024
424B3
Prospectus Filed
Mar 12, 2024
4
Insider Trading
Feb 29, 2024
4
Insider Trading
Feb 01, 2024
8-K
Current Report
Feb 01, 2024
424B3
Prospectus Filed
Jan 23, 2024
SC 13G/A
Major Ownership Report
Jan 23, 2024
4
Insider Trading
Jan 23, 2024
4
Insider Trading
Dec 22, 2023
4/A
Insider Trading

Peers (Alternatives to Clever Leaves Holdings Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
380.6B
85.2B
-0.84% 1.87%
10.83
4.47
6.46% 95.94%
333.8B
60.1B
-3.08% 18.97%
914.53
5.55
1.40% -97.49%
156.9B
46.5B
-0.94% -29.07%
-113.02
3.37
42.59% -114.62%
153.4B
28.2B
-2.65% 20.18%
22.84
5.44
7.09% 2.52%
91.0B
27.1B
1.44% -6.08%
16.06
3.35
-0.60% 23.36%
16.2B
15.8B
6.68% 47.26%
-28.08
1.02
6.17% 76.47%
MID-CAP
4.6B
1.7B
-15.20% 8.04%
12.8
2.74
49.61% 324.78%
4.3B
4.7B
-2.22% -15.29%
-335.7
0.92
4.58% 90.97%
3.8B
8.8B
12.34% 25.79%
-6.47
0.44
7.79% -163.11%
2.1B
644.4M
-19.16% 20.49%
15.22
3.25
29.14% 50.51%
SMALL-CAP
1.8B
700.5M
20.31% -
-1.29
2.63
16.26% -147.49%
24.2M
70.0M
1.33% -38.14%
0.35
0.34
-19.54% 888.31%
18.7M
-
-10.40% 69.70%
-1.01
0.22
2882.68% -138.52%
14.8M
111.1M
-18.24% -6.20%
-0.93
0.13
-10.43% 84.90%
929.3K
20.0M
-54.17% -94.76%
-0.07
0.05
137.71% 66.04%

Clever Leaves Holdings Inc. News

Latest updates
InvestorsObserver4 hours ago

Clever Leaves Holdings Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue-23.3%3,820,0004,981,0003,978,0005,792,0002,867,0004,100,0005,041,0004,194,0004,031,0003,672,0003,477,00017,121,0003,917,0001,939,0002,914,000-
Gross Profit-28.8%1,942,0002,726,0002,234,000-2,043,0001,299,0002,481,0002,593,000970,0001,931,0001,768,0002,140,0002,272,0002,073,000907,0002,161,000-
Operating Expenses-9.9%5,319,0005,901,0006,364,00033,667,50025,623,0007,829,00012,312,00031,122,00011,615,00011,371,0009,908,0009,590,0006,784,0008,232,00011,335,000-
  S&GA Expenses24.1%582,000469,000549,000-178,000615,000728,000732,0001,879,000208,000241,000587,000285,000508,000603,0001,181,000-
  R&D Expenses-27.5%292,000403,000212,000605,000343,000359,000412,000509,000454,000305,000278,000-----
EBITDA Margin31.3%-2.53-3.68-3.56-3.88-3.47-1.75-2.42-2.65-0.70-0.95-1.01-0.90-1.98-2.51-3.42-5.40
Interest Expenses-----516,000--375,000117,000--548,000-65,000----
Income Taxes-----------------
Earnings Before Taxes-123.0%-7,271,000-3,261,000-4,151,000-35,709,000-24,841,0001,856,000-13,761,000-22,994,0001,009,000-8,942,000-13,754,000-846,000-6,106,000-8,748,000-10,175,000-
EBT Margin29.7%-2.71-3.86-3.75-4.07-3.69-1.95-2.64-2.91-0.80-1.05-1.11-1.00-2.15-2.72-3.72-5.86
Net Income-42.9%-5,138,000-3,595,000-4,081,000-28,816,000-20,163,000-1,046,000-16,140,000-24,000,000995,000-8,956,000-13,765,000-2,686,000-5,094,000-8,753,000-10,186,000-
Net Income Margin30.3%-2.24-3.22-3.23-3.72-3.79-2.31-2.84-2.97-0.86-1.08-1.15-1.03-1.85-2.34-3.20-5.05
Free Cashflow-33.4%-2,309,000-1,731,000-6,112,000-4,547,000-5,640,000-8,599,000-11,586,000-9,370,000-10,328,000-10,972,000-12,843,000-4,061,000-3,586,000-9,103,000-8,876,000-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42019Q4
Assets-11.8%38.0043.0046.0052.0081.0010512711614115015916696.00
  Current Assets-2.6%18.0018.0021.0026.0041.0044.0069.0060.0068.0077.0087.0096.0024.00
    Cash Equivalents27.5%6.005.006.0012.0018.0019.0045.0038.0046.0057.0069.0079.0013.00
  Inventory3.2%8.007.008.008.0017.0017.0016.0015.0014.0013.0012.0010.005.00
  Net PPE-2.6%13.0013.0013.0014.0029.0030.0030.0031.0030.0029.0027.0026.0024.00
  Goodwill---------19.0019.0019.0019.0020.00
Liabilities-8.9%8.009.009.0012.0012.0021.0045.0043.0053.0071.0074.0071.0046.00
  Current Liabilities-9.5%7.008.008.009.008.009.0027.0027.0033.0057.0031.0030.006.00
  Long Term Debt---------6.00-27.007.0027.00
Shareholder's Equity-12.5%30.0034.0037.0040.0070.0085.0082.0073.0088.0079.0084.0095.0050.00
  Retained Earnings-2.7%-193-188-184-180-152-131-130-114-90.74-91.73-82.78-69.01-31.93
  Additional Paid-In Capital0.4%22322322222122221721318817817116716477.00
Accumulated Depreciation5.0%8.008.008.007.008.007.006.006.005.004.004.003.001.00
Shares Outstanding13.3%2.002.001.001.001.001.001.001.001.001.001.001.000.00
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations-30.5%-2,201-1,687-6,077-5,097-5,385-8,213-10,371-8,038-8,699-8,869-10,627-3,682-3,736-7,322-7,221-
  Share Based Compensation-88.0%52.00434468-2639581,1485003,3143,2643,3231,550747489-297416-
Cashflow From Investing6275.0%2,717-44.00-35.00550-2552,112-1,215-1,332-1,629-2,103-2,216-379150-1,781-1,655-
Cashflow From Financing360.6%760165-107-2503,886-19,03818,691883-585-1,0972,63377,2063,653-5,98716,966-
  Buy Backs--------------6,250--

CLVR Income Statement

2023-09-30
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Revenue, net$ 3,820,000$ 2,867,000$ 12,779,000$ 12,008,000
Cost of sales(1,878,000)(1,568,000)(5,877,000)(5,635,000)
Gross profit1,942,0001,299,0006,902,0006,373,000
Expenses    
General and administrative4,155,0005,442,00014,327,00018,865,000
Sales and marketing582,000615,0001,600,0002,075,000
Research and development292,000343,000907,0001,114,000
Restructuring expenses0(82,000)03,761,000
Goodwill impairment19,000,00019,000,000
Depreciation and amortization290,000305,000750,000950,000
Total expenses5,319,00025,623,00017,584,00045,765,000
Loss from operations(3,377,000)(24,324,000)(10,682,000)(39,392,000)
Other Expense (Income), net    
Interest and amortization of debt issuance cost5,000(58,000)23,0002,696,000
Gain on remeasurement of warrant liability(60,000)(196,000)(5,000)(2,009,000)
Gain on investment000(6,851,000)
Investment impairment3,705,00003,705,0000
Loss on debt extinguishment, net0002,263,000
Foreign exchange loss275,000669,000297,0001,144,000
Other (income) expense, net(31,000)102,000(19,000)111,000
Total other expenses (income), net3,894,000517,0004,001,000(2,646,000)
Loss before income taxes and equity investment loss(7,271,000)(24,841,000)(14,683,000)(36,746,000)
Deferred income tax (recovery)0(6,650,000)0(6,650,000)
Equity investment share of loss00064,000
Loss from continuing operations(7,271,000)(18,191,000)(14,683,000)(30,160,000)
Income (loss) from discontinued operations2,133,000(1,972,000)1,869,000(7,189,000)
Net loss$ (5,138,000)$ (20,163,000)$ (12,814,000)$ (37,349,000)
Net loss per share:    
Basic from continuing operations (USD per share)$ (4.60)$ (12.93)$ (9.70)$ (24.70)
Diluted from continuing operations (USD per share)(4.60)(12.93)(9.70)(24.70)
Basic from discontinued operations (USD per share)1.35(1.41)1.23(5.90)
Diluted from discontinued operations (USD per share)1.35(1.41)1.23(5.90)
Net loss per share - basic (USD per share)(3.25)(14.33)(8.47)(30.59)
Net loss per share - diluted (USD per share)$ (3.25)$ (14.33)$ (8.47)$ (30.59)
Weighted-average common shares outstanding - basic (in shares)1,580,4561,407,4191,513,5751,221,107
Weighted-average common shares outstanding - diluted (in shares)1,580,4561,407,4191,513,5751,221,107
Weighted-average common shares outstanding per share, basic (USD per share)$ (3.25)$ (14.33)$ (8.47)$ (30.59)
Weighted-average common shares outstanding per share, diluted (USD per share)$ (3.25)$ (14.33)$ (8.47)$ (30.59)

CLVR Balance Sheet

2023-09-30
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current:  
Cash and cash equivalents$ 6,472$ 12,449
Restricted cash66439
Accounts receivable, net1,7462,252
Prepaids, deposits and other receivables1,9412,708
Inventories, net7,7098,399
Total current assets17,93426,247
Investment – Cansativa1,8965,679
Property, plant and equipment, net of accumulated depreciation of $8,389 and $7,120 for September 30, 2023 and December 31, 2022, respectively12,75213,963
Assets held for sale - Land1,5001,500
Intangible assets, net2,8213,354
Operating lease right-of-use assets, net8201,303
Other non-current assets5452
Total Assets37,77752,098
Current:  
Accounts payable2,0882,299
Accrued expenses and other current liabilities3,2254,238
Loans and borrowings, current portion477465
Warrant liability108113
Operating lease liabilities, current portion5121,239
Deferred revenue4371,072
Total current liabilities6,8479,426
Loans and borrowing — long-term8591,065
Operating lease liabilities — long-term3661,087
Other long-term liabilities16112
Total Liabilities8,08811,690
Contingencies and commitments
Shareholders’ equity  
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of September 30, 2023 and December 31, 202200
Common shares, without par value, unlimited shares authorized: 1,726,145 and 1,454,559 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively00
Additional paid-in capital223,407221,313
Accumulated deficit(193,718)(180,905)
Total shareholders' equity29,68940,408
Total liabilities and shareholders' equity$ 37,777$ 52,098
CLVR
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.
 CEO
 WEBSITEcleverleaves.com
 EMPLOYEES400

Clever Leaves Holdings Inc. Frequently Asked Questions


What is the ticker symbol for Clever Leaves Holdings Inc.? What does CLVR stand for in stocks?

CLVR is the stock ticker symbol of Clever Leaves Holdings Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clever Leaves Holdings Inc. (CLVR)?

As of Wed Mar 27 2024, market cap of Clever Leaves Holdings Inc. is 8.55 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLVR stock?

You can check CLVR's fair value in chart for subscribers.

What is the fair value of CLVR stock?

You can check CLVR's fair value in chart for subscribers. The fair value of Clever Leaves Holdings Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Clever Leaves Holdings Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CLVR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Clever Leaves Holdings Inc. a good stock to buy?

The fair value guage provides a quick view whether CLVR is over valued or under valued. Whether Clever Leaves Holdings Inc. is cheap or expensive depends on the assumptions which impact Clever Leaves Holdings Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLVR.

What is Clever Leaves Holdings Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, CLVR's PE ratio (Price to Earnings) is -0.21 and Price to Sales (PS) ratio is 0.46. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLVR PE ratio will change depending on the future growth rate expectations of investors.